Urological cancer, Malmö
241 – 250 of 563
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer
- Contribution to journal › Article
-
Mark
Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer : A Semiecologic, Nationwide, Population-based Study
- Contribution to journal › Article
-
Mark
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301) : An open-label, phase 3, randomised controlled trial
- Contribution to journal › Article
-
Mark
Reply to Glen D. Santok and Koon H. Rha' Letter to the Editor re : Pär Stattin, Fredrik Sandin, Frederik Birkebæk Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.0
- Contribution to journal › Letter
-
Mark
Long-term functional outcomes after radical cystectomy with ileal bladder substitute : does the definition of continence matter?
- Contribution to journal › Article
-
Mark
Tailored perioperative antimicrobial prophylaxis in urological surgery : myth or reality?
- Contribution to journal › Article
-
Mark
Quantitative Imaging-Biomarker in Prostate Cancer. Validation of Automated Bone Scan Index in the Context of Radiographic Disease Progression in Metastatic Castration Resistant Prostate Cancer
- Thesis › Doctoral thesis (compilation)
-
Mark
Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis
- Contribution to journal › Article
-
Mark
Habits and self-assessed quality of life, negative intrusive thoughts and depressed mood in patients with prostate cancer : a longitudinal study
- Contribution to journal › Article
-
Mark
Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele
- Contribution to journal › Article
